Actively Recruiting
Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.
Led by Althaia Xarxa Assistencial Universitària de Manresa · Updated on 2025-01-31
12
Participants Needed
1
Research Sites
256 weeks
Total Duration
On this page
Sponsors
A
Althaia Xarxa Assistencial Universitària de Manresa
Lead Sponsor
S
Societat Catalana d'Oftalmologia
Collaborating Sponsor
AI-Summary
What this Trial Is About
This is a multicentric, randomized, single-blinded clinical trial to evaluate the efficacy and safety of 3D printing for the planification and simulation of orbital decompression surgery for thyroid-associated orbitopathy.
CONDITIONS
Official Title
Evaluation of the Efficacy and Safety of 3D Printing for Orbital Surgery.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of inactive thyroid-associated orbitopathy requiring bilateral orbital decompression (moderate-severe in EUGOGO classification).
- Volunteers older than 18 years old.
- Ability to read.
- Acceptation to participate and signature of informed consent.
You will not qualify if you...
- Younger than 18 years old.
- Previous orbital surgery.
- Any coexisting disease preventing follow-up.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Eduard Pedemonte Sarrias
Manresa, Barcelona, Spain, 08243
Actively Recruiting
Research Team
E
Eduard Pedemonte-Sarrias, MD, PhD
CONTACT
A
Anna Arnau, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here